Literature DB >> 23820828

Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies.

Daniel C Javitt.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23820828     DOI: 10.1176/appi.ajp.2013.13040503

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

Review 1.  Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.

Authors:  Joshua T Kantrowitz; Neal R Swerdlow; Walter Dunn; Sophia Vinogradov
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-02-22

2.  Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke.

Authors:  Kendra M Cherry; Eric J Lenze; Catherine E Lang
Journal:  J Neurophysiol       Date:  2014-03-26       Impact factor: 2.714

3.  D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.

Authors:  Cheri A Levinson; Thomas L Rodebaugh; Laura Fewell; Andrea E Kass; Elizabeth N Riley; Lynn Stark; Kimberly McCallum; Eric J Lenze
Journal:  J Clin Psychiatry       Date:  2015-06       Impact factor: 4.384

4.  Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.

Authors:  Joshua T Kantrowitz; Michael L Epstein; Odeta Beggel; Stephanie Rohrig; Jonathan M Lehrfeld; Nadine Revheim; Nayla P Lehrfeld; Jacob Reep; Emily Parker; Gail Silipo; Merav Ahissar; Daniel C Javitt
Journal:  Brain       Date:  2016-12       Impact factor: 13.501

Review 5.  Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.

Authors:  Helga Rodrigues; Ivan Figueira; Alessandra Lopes; Raquel Gonçalves; Mauro Vitor Mendlowicz; Evandro Silva Freire Coutinho; Paula Ventura
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.